Genomic and Epigenomic Profiles of Asian Endemic Cancers

Dr.Tan is a Professor at the Duke-NUS Medical School and Deputy Executive Director of the Biomedical Research Council (Agency for Science, Technology, and Research). He directs PRISM, the SingHealth DukeNUS Institute of Precision Medicine, and was Program Director of POLARIS, which established the first CAP-certified facilities for next-generation sequencing and the first clinically implemented NGS panel in South East Asia.

He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry. Other awards include the President's Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), SingHealth Investigator Excellence Award, Chen New Investigator Award (Human Genome Organization), President's Science Award, and the Japanese Cancer Association International Award.

Dr. Tan is an elected member of the American Society for Clinical Investigation (ASCI), the Bioethics Advisory Committee (BAC), a national body that provides advice to the Singapore government on ethical issues related to biomedical research, a Board Member of the International Gastric Cancer Association, and a Member of the AACR International Affairs Committee.